NSTEMI
35
2
4
16
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
2.9%
1 terminated out of 35 trials
94.1%
+7.6% vs benchmark
31%
11 trials in Phase 3/4
6%
1 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 16 completed trials
Clinical Trials (35)
Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome
Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock
AI-Powered ECG Detecting Culprit Vessel Blood Flow Abnormality in ACS
Efficacy of Immediate Versus Staged Complete Revascularization in Patients With NSTE-ACS and Multivessel Disease (FUTURE II)
DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction
Prognostic Impact of Guideline-recommended Timing for Invasive Strategy in NSTEMI
Assessment of Individual Risk of Cardiovascular Events by Platelet FcGammaRIIa
Telehealth Group Counseling and Preventive Care for Women
Sweetheart-Register: Risk Management of Diabetics with Acute Myocardial Infarction
Efficacy of Oral Ivabradine in Patients Presenting With NSTEMI
Pivotal, Single-arm Clinical Trial to Assess the Efficacy and Safety of the MedHub AutocathFFR Software Device
Breisgau Pheno Heart Study
Evaluation of the Effect of Long-term Lipid-lowering Therapy in STEMI Patients With Coronavirus Infection COVID-19
OPTIMISER Registry - A Prospective Cohort Study to Describe the OPTIMal Management and Outcomes of PatIents PreSEnting With Acute MyocaRdial Infarction
Mobile Advanced Multi-Parameter Reporting in Patients Wearing a Novel Device: Utilization During Cardiac Rehabilitation
A Pilot Proof of Concept, Randomized Controlled, Single-Center Study of a Decision Aid Tool for Older Patients Considering LHC as Treatment for NSTEMI
Bare Metal Stent Versus Drug Coated Balloon With Provisional Stenting in Non-ST-Elevation Myocardial Infarction
Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome
Compressive Elastic Dressing Versus TR Band
Platelet Inhibition With Ticagrelor 60 mg Versus Ticagrelor 90 mg in Elderly Patients With ACS